Investment Case · Oct 8, 2026

Active

$NOW

SHORT

ServiceNow, Inc. · NYSE

Premium Multiple, Slowing Growth, AI Pricing Risk

RResearch Desk @research_desk Editorial Verified25 cases · 17% hit · -0.8% avgConviction 3/5 Into Q3 earnings (Oct 28) and Q4 guidance (late Jan 2027)

Thesis

NOW still trades at a premium software multiple while guidance points to a clear growth step-down in Q3, and Q2 was flattered by FX and a federal pull-forward. Enterprise budget scrutiny and the shift from seat pricing to AI consumption pricing leave little room for a miss on growth or margin.

Performance Since Publication

Against the thesis

Short Return

-12.3%

At Publication

$137.87

Last

$154.78

Stock +12.3%

To Target

-19.9%

Company Snapshot

SERVICENOW, INC.

Services-Prepackaged Software

Large Cap

Market Cap

$155.2B

P/E (TTM)

—

Dividend Yield

—

Beta

—

Avg Volume

—

200-Day Avg

—

Next Earnings

—

Employees

29.2K

ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas…

www.servicenow.com

Price Levels

Entry

$139.00

Price Target

$124.00

Stop

$150.00

Catalysts

1Q3 2026 earnings, scheduled Oct 28 (cRPO growth versus the 20% guide, subscription gross margin).
2Q4 and FY2027 guidance, expected with Q4 results in late January 2027 (growth decay and AI margin drag).
3Software-sector budget data and rates moves that reopen the AI-disruption debate through year-end.

Key Risks

1NOW has beaten the top of guidance in Q1 and Q2, and a third beat with a raise would squeeze the short.
2AI ACV passed $1B, and a faster ramp toward the $1.5B 2026 target could re-rate the multiple.
3The stock is already about 28% below its 52-week high, and a mean target above spot plus buybacks provide support.

Read the Full Thesis

The market is treating NOW as the AI winner in enterprise software. The shares are about $138 with a trailing P/E near 86, and the consensus target of about $145 sits only slightly above the price. Few investors are positioned for a growth miss. Q2 (reported Jul 22) beat, but the quality of the beat is mixed. Subscription revenue grew 24.5% reported and 23% in constant currency. Management said part of the upside came from US Federal demand that pulled on-premise revenue forward from Q3 into Q2. The result is a lower base for Q3: Q3 subscription revenue is guided up 20.5% with cRPO growth of 20%. That is a roughly 3-point step down in one quarter. The full-year raise was only modest. Margins are the second pressure point. Management flagged short-term gross margin pressure from hyperscaler partnerships and faster AI adoption. Subscription gross margin is guided to 81%. AI consumption pricing carries compute costs that classic seat licences did not. If enterprise buyers push back on AI price points, the higher growth and margin mix the multiple depends on is not delivered. The macro angle is enterprise IT budgets. Higher-for-longer rates and CFO scrutiny of software spend put AI add-ons under pressure to prove ROI. That is a bigger risk for a stock priced for acceleration than for one priced for slowdown. For the short to work, Q3 cRPO and subscription growth need to land at or below guidance, and AI ACV needs to look like cannibalisation or discounting rather than incremental revenue.

Updates Since Publication

Oct 13, 2026 · Price 140.32
Weekly check-in: Weakened. Stock stays near entry, but pre-earnings setup leans toward another cRPO beat The stock is near the $139 entry, but the evidence for a growth miss has mostly moved the other way this week. Analysts are raising targets and calling for a cRPO beat ahead of Q3 on Oct 28. Only the federal pull-forward point is confirmed, and it is already in guidance. The Q3 growth step-down is also smaller on cRPO than the case states.
Oct 20, 2026 · Price 149.46
Weekly check-in: Challenged. Shares pressed the $150 stop zone as targets rise before Oct 28 earnings Since the Oct 13 check-in the shares have moved from the low $140s to about $149.5, per Yahoo's Oct 20 intraday quote, with a session high just above $150. That is the case's stop level and about 7% above the $139 entry. Sell-side preview work has turned more constructive, which weakens the short's premise that few investors expect a good print. The core Q3 evidence (cRPO versus the 20% guide, gross margin) is still unreported, so the thesis is not disproved but now has little cushion.
Oct 24, 2026 · Price 158.96
Stop hit on Oct 24 at 158.96. Close the case and note what you learned, or move the level if your view changed.

The Other Side

Disagree? Make the opposite case with your own levels. Both get scored, so the debate gets a winner.

Track This Case

Copy it into your own account, adjust it to your view, and get an alert when the price reaches its levels.

Investment case published by @research_desk. It reflects the author’s own views at the time of publication and is for information only. It is not investment advice or a recommendation to buy or sell any security. Prices and company data are delayed and may be inaccurate. User content is not verified. Editorial cases are written by our research desk with AI research assistance and reviewed by the team. · How we measure performance